GlassScriptPhysician profile
Jill M Strause
NPI 1699293167
$2,831.73
in general payments reported to CMS, 2019-2025
11 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $301 · 2023: $352 · 2024: $1,067 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.26 |
| Education | $267.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,246.06 | 2023-2025 | Rybrevant, Tecvayli, Carvykti |
| Alexion Pharmaceuticals, INC. | $666.63 | 2022-2025 | Soliris, Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $274.61 | 2023-2025 | Reblozyl, Opdivo, Opdualag |
| Sobi, INC | $204.77 | 2023-2024 | |
| Incyte Corporation | $189.11 | 2022-2025 | Jakafi, Monjuvi |
| Lilly USA, LLC | $125.00 | 2024 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $34.07 | 2025 | Lynozyfic |
| Abbvie INC. | $27.89 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $25.44 | 2025 | Onivyde |
| Novartis Pharmaceuticals Corporation | $19.66 | 2023 | |
| Stryker Corporation | $18.49 | 2025 | Sage Self Oral Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Strause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.